CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
SUNDAY 04 SEPTEMBER, 2016
Introduction 1446
Workstation 1: The normal human thoracic cavity
Fergus Gleeson (Oxford, United Kingdom), Konstantina Kontogianni (Heidelberg, Germany)
Workstation 2: Pleural effusion and/or pleural thickening
Ioannis Psallidas (Oxford, United Kingdom), Horiana Grosu (Houston, United States of America)
Workstation 3: Case studies
John Wrightson (Oxford, United Kingdom)
1447
1448
1449
Workstation 4: Guided pleural aspiration and lymph node biopsy using models
Coenraad Frederik Nicolaas Koegelenberg (Cape Town, South Africa), Duneesha De Fonseka (Bristol, United
Kingdom), Najib M. Rahman (Oxford, United Kingdom)
Room ICC Capital Suite 6 Session 217 13:00 - 14:00
Registration for this session is additional to the congress registration fee and is €100 on site, €90 standard or €70 for early bird
registration.
Meet the expert: ME1 Biomarkers for interstitial lung disease - FULLY BOOKED
Aims : Access educational materials here
To critically review the most recent findings in interstitial lung disease (ILD) biomarker research including discovery tools; and to
understand how biomarkers could be used to clinically manage specific forms of ILD such as idiopathic pulmonary fibrosis (IPF) or
connective tissue disease (CTD)-ILD.
Tag(s) : Translational
Target audience : Immunologist, Pharmaceutical industry representative, Pulmonologist, Researcher, Resident, Scientist
13:00
Biomarkers for interstitial lung disease
Martin Kolb (Hamilton, Canada)
Room ICC Capital Suite
13
1450
1422
Session 216 13:00 - 14:00
Registration for this session is additional to the congress registration fee and is €100 on site, €90 standard or €70 for early bird
registration.
Meet the expert: ME2 New treatment approaches for idiopathic pulmonary fibrosis - FULLY
BOOKED
Aims : Access educational materials here
To review the drug development landscape for idiopathic pulmonary fibrosis (IPF) in the light of the newly approved anti-fibrotic drugs
pirfenidone and nintedanib; and to discuss the preclinical, methodological, and clinical challenges in IPF drug development.
Tag(s) : Translational
Target audience : Clinician, Pulmonologist, Researcher, Respiratory physician, Scientist, Trainee
13:00
New treatment approaches for IPF
Luca Richeldi (Southampton, United Kingdom)
Room ICC Capital Suite
15
1421
Session 218 13:00 - 14:00
Registration for this session is additional to the congress registration fee and is €100 on site, €90 standard or €70 for early bird
registration.
Meet the expert: ME3 Fiberoptic bronchoscopy in children
Aims : Access educational materials here
To describe the more common indications for fiberoptic bronchoscopy in children; to review the risks and benefits of fiberoptic
bronchoscopy for the patient.
Track(s) : Paediatric
Tag(s) : Clinical
Target audience : Otolaryngologist, Paediatrician, Pulmonologist, Student, Junior member, Fellow
13:00
Fiberoptic bronchoscopy in children
Angelo Barbato (Padova, PD, Italy)
1423
21 26.08.2016